Pharmacoeconomics-Open
Scope & Guideline
Empowering Healthcare Decisions Through Open Research
Introduction
Aims and Scopes
- Cost-Effectiveness Analysis (CEA):
The journal publishes extensive research on cost-effectiveness analyses of various healthcare interventions, including pharmaceuticals, medical devices, and treatment protocols, providing a comprehensive understanding of their economic value. - Health Technology Assessment (HTA):
Pharmacoeconomics-Open focuses on health technology assessments that evaluate the clinical efficacy, safety, and economic implications of new treatments and technologies, guiding stakeholders in healthcare decision-making. - Budget Impact Analysis (BIA):
The journal includes studies on budget impact analyses, evaluating the financial implications of adopting new therapies or technologies within specific healthcare systems, aiding in resource allocation and policy planning. - Patient-Centered Outcomes:
Research highlighting patient-reported outcomes and quality of life assessments is central to the journal's scope, emphasizing the importance of patient perspectives in evaluating healthcare interventions. - Methodological Innovations in Economic Evaluation:
Pharmacoeconomics-Open encourages submissions that explore new methodologies in economic evaluation, including modeling techniques and statistical approaches, to enhance the rigor and applicability of pharmacoeconomic studies.
Trending and Emerging
- Integration of Artificial Intelligence (AI):
Recent publications emphasize the role of AI in automating health economic modeling and decision-making processes, showcasing innovative applications that enhance efficiency and accuracy in economic evaluations. - Real-World Evidence (RWE):
There is a growing trend towards incorporating real-world evidence in economic evaluations, with studies focusing on the effectiveness and cost implications of interventions in routine clinical practice, rather than controlled trial settings. - Value-Based Healthcare Models:
Emerging research emphasizes value-based healthcare approaches that assess treatments based on their outcomes relative to costs, reflecting a shift in focus from volume-based care to value-driven systems. - Patient-Centered and Multi-Criteria Decision Analysis:
An increasing number of studies are employing multi-criteria decision analysis (MCDA) frameworks that incorporate diverse stakeholder preferences, including patient values, in the evaluation of healthcare interventions. - Global Health Economics:
The journal is seeing a rise in submissions addressing global health economics, particularly in low- and middle-income countries, highlighting unique challenges and opportunities in these contexts.
Declining or Waning
- Traditional Cost-Utility Analysis:
There is a noticeable decline in the frequency of traditional cost-utility analyses focusing solely on generic health states, as researchers increasingly adopt more nuanced approaches that incorporate broader patient-reported outcomes. - Single-Condition Focused Studies:
Research solely centered on specific diseases or conditions, such as individual cancers or chronic illnesses, is becoming less prevalent, with a shift towards studies that consider broader healthcare systems and multiple conditions. - Static Economic Models:
The use of static economic models that do not account for real-world variability and long-term outcomes is decreasing, as there is a growing preference for dynamic modeling approaches that reflect changing patient populations and treatment landscapes.
Similar Journals
Applied Health Economics and Health Policy
Empowering decision-makers with applied health economics.Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.
Farmeconomia-Health Economics and Therapeutic Pathways
Connecting research and policy for effective healthcare solutions.Farmeconomia-Health Economics and Therapeutic Pathways is a pioneering journal within the field of health economics, dedicated to exploring the intersections of health policy, therapeutics, and economic evaluations. Published by SEED MEDICAL PUBLISHERS, this Open Access journal has been at the forefront of advancing knowledge since 2012, ensuring that vital research is readily accessible to a global audience without subscription barriers. The journal aims to facilitate the dissemination of insightful studies, systematic reviews, and theoretical discussions that determine the cost-effectiveness of therapeutic options, ultimately guiding evidence-based healthcare decisions. Based in *Torino, Italy*, this journal is committed to serving researchers, healthcare professionals, and students who are eager to contribute to and stay updated on the latest developments in health economics and policy implementation. With its broad-ranging scope and dedication to quality research, Farmeconomia stands as an essential resource for anyone engaged in the complex dynamics of health systems and their economic implications.
American Economic Journal-Economic Policy
Exploring Evidence-Based Solutions in Economic PolicyAmerican Economic Journal - Economic Policy, published by the American Economic Association, stands at the forefront of economic research, focusing on significant policy implications and evidence-based evaluations. With an ISSN of 1945-7731 and an E-ISSN of 1945-774X, this esteemed journal has maintained its influence and credibility in the field since its inception in 2009. Ranked in the Q1 category for Economics, Econometrics and Finance and ranking #7 out of 288 in Scopus, it boasts a remarkable 97th percentile ranking, making it a premier source for cutting-edge research and policy discussion. The journal's rigorous peer-reviewed articles aim to bridge the gap between academic research and real-world economic policy, serving as an essential resource for researchers, professionals, and students who seek to engage with and contribute to the evolving landscape of economic policy. With open access options not currently available, readers are encouraged to subscribe or access articles through academic institutions for comprehensive insights into the economic challenges and innovations shaping our world.
Journal of Health Economics and Outcomes Research
Driving innovation in health services research.Journal of Health Economics and Outcomes Research, published by COLUMBIA DATA ANALYTICS, LLC, serves as a vital resource in the field of health policy and public health, providing researchers, professionals, and students with open access to pioneering studies since its inception in 2013. With its ISSN and E-ISSN both listed as 2327-2236, this journal aims to disseminate high-quality research that evaluates healthcare efficiency and outcomes. Situated in the United States, at 145 Hudson St., Suite 205, New York, NJ 10013, it has made significant strides in its category quartiles within the 2023 rankings, achieving Q2 status in both Health Policy and Public Health, Environmental and Occupational Health. Furthermore, it maintains respectable Scopus rankings, with a percentile of 51st in health policy and 49th in public health. By bridging gaps in health economics and policy discourse, the journal stands as an indispensable platform for advancing knowledge and fostering innovation in health services research.
International Journal of Health Economics and Management
Connecting disciplines to enhance health policy and management.International Journal of Health Economics and Management is a premier academic journal published by SPRINGER, focusing on innovative research at the intersection of health economics and management practices. Established in 2015, this journal caters to a diverse range of disciplines, integrating rigorous economic analysis with vital health policy discussions. With an impressive impact factor reflective of its influential publications, it holds a distinguished Q1 ranking in Economics, Econometrics, and Finance, and a Q2 ranking in Health Policy for 2023. The journal provides an open access model, enabling wider dissemination of research findings to academics, policymakers, and healthcare professionals globally. Researchers and students alike will find this journal invaluable for its commitment to advancing knowledge in health economics and improving healthcare management practices through empirical studies and theoretical insights. For more information, or to access articles, please refer to the journal's platform.
CLINICAL THERAPEUTICS
Transforming therapeutic strategies through rigorous research.Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.
SOCIO-ECONOMIC PLANNING SCIENCES
Transforming data into actionable socio-economic strategies.SOCIO-ECONOMIC PLANNING SCIENCES, published by Elsevier Science Inc, is a leading journal in the interdisciplinary fields of economics and social sciences, with a strong focus on planning and development strategies from a socio-economic perspective. With an impact factor reflecting its prestigious standings, it has earned Q1 rankings in multiple categories, including Economics and Econometrics, Geography, Planning and Development, and Strategy and Management as of 2023. Its rigorous peer-reviewed framework ensures that the research disseminated is of the highest quality, making it a crucial resource for researchers, practitioners, and policymakers alike. The journal, which has been in continuous publication since 1967, also benefits from a wide reach through Scopus rankings, placing it in the top percentiles for numerous academic disciplines. By facilitating access to innovative methodologies, applied theories, and empirical analyses related to socio-economic planning, SOCIO-ECONOMIC PLANNING SCIENCES aims to foster a deeper understanding of interconnected social and economic systems, thus contributing to informed decision-making processes across various sectors.
BMC HEALTH SERVICES RESEARCH
Empowering healthcare innovation with open-access insights.BMC Health Services Research is a leading open-access journal dedicated to advancing the field of health policy and services research. Published by BMC since 2001 and based in the United Kingdom, this journal has established itself as an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of health care systems and policies. With an impressive 2023 Q1 ranking in the Health Policy category and a Scopus rank of 90/310, it clearly demonstrates its commitment to high-quality, impactful research. The journal's open-access model ensures that research findings are accessible to a global audience, promoting collaboration and innovation in health services. Spanning from 2001 to 2024, BMC Health Services Research is poised to remain at the forefront of health services research, making significant contributions to policy formulation and practice improvement in the healthcare sector.
ClinicoEconomics and Outcomes Research
Exploring the Intersection of Economics and Health DeliveryClinicoEconomics and Outcomes Research is a prestigious open-access journal published by DOVE MEDICAL PRESS LTD, located in New Zealand. Since its inception in 2009, it has established itself as a vital resource for researchers and practitioners in the fields of economics, health policy, and outcomes research. With a commendable impact reflected in its rankings—Q1 in Economics, Econometrics and Finance and Q2 in Health Policy—the journal effectively bridges the gap between economic evaluation and healthcare delivery. This publication is particularly significant for those focused on the economic implications of health interventions, policy analysis, and decision-making processes in healthcare systems. As an open-access journal, ClinicoEconomics and Outcomes Research ensures that its valuable content is widely accessible, enhancing knowledge dissemination and fostering collaboration among academia, industry, and policymakers. With an ambition to contribute to the improvement of health outcomes through rigorous research, it invites submissions that address the multifaceted challenges facing the economics of healthcare today. Join the scholarly dialogue where innovative ideas in health economics thrive!
HEALTH TECHNOLOGY ASSESSMENT
Fostering multidisciplinary approaches to health technology assessment.HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.